Add BrightSurf on Google Email

Repeated exposure to wildfires can incrementally increase heart failure risk

A study published in JACC found that long-term exposure to wildfire smoke may increase the risk of heart failure, particularly among older adults, women, and those living in lower-income areas. The risk was found to be higher with increased levels of PM2.5 air pollution from wildfires compared to other types of air pollution.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateJun 23, 2025

EuroIntervention achieves Record Impact Factor of 9.5

The Journal EuroIntervention has recorded an impressive Impact Factor of 9.5, making it one of the most cited publications in interventional cardiology. This achievement is attributed to the journal's commitment to publishing high-quality clinical articles and expert commentaries.

SourcePCR·DateJun 18, 2025

University Hospitals Harrington Heart & Vascular Institute unveils new structural heart program, cardiac catheterization lab at UH Lake West Medical Center

The new program offers minimally invasive treatments for cardiovascular issues, including transcatheter aortic valve replacement and left atrial appendage occlusion. The cardiac catheterization lab features state-of-the-art equipment, allowing improved diagnostic imaging and safer procedures.

Advance in creating organoids could aid research, lead to treatment

Researchers at Stanford Medicine successfully grew heart and liver organoids with integrated blood vessels, allowing them to overcome the current size limit. These vascularized organoids can grow larger and reach a more mature state, making them more useful as biological models for research and potential treatment of various diseases.

SourceStanford Medicine·JournalScience·TypeExperimental study·DateJun 5, 2025

New technology developed at the Lewis Katz School of Medicine at Temple University promises faster, earlier diagnosis of deadly form of heart failure

A novel screening approach called VEST uses virtual echocardiography to identify patients at high risk of pulmonary arterial hypertension, a life-threatening form of heart failure. The tool has been shown to generate accurate PAH risk scores without manual calculations and can guide timely referrals for expert care.

SourceTemple University Health System·JournalAmerican Heart Journal·DateJun 4, 2025

The heart of female elite athletes adapts differently than those of male elite athletes

Research led by Amsterdam UMC reveals the hearts of female elite athletes have different characteristics compared to their male counterparts. Female athletes exhibit dilation of the heart chambers, whereas males show thickening in combination with a dilation of the heart muscle. This finding can aid doctors in identifying possible hear...

SourceAmsterdam University Medical Center·JournalEuropean Heart Journal - Cardiovascular Imaging·TypeRandomized controlled/clinical trial·DateJun 2, 2025

Never too old: medication improves survival rates after a first heart attack even in patients over 90 years old

A study found that prescribing guideline-directed medical treatment to patients 90 years and older following their first heart attack can improve survival rates. The greatest benefit was observed in those who received all four recommended therapies, including beta-blockers and renin-angiotensin-aldosterone system inhibitors.

SourceElsevier·JournalCanadian Journal of Cardiology·TypeData/statistical analysis·DateMay 22, 2025

Male bodybuilders face high risk of sudden cardiac death, especially those who compete professionally

A study published in the European Heart Journal found that male bodybuilders have a high risk of sudden cardiac death, with professional bodybuilders facing a more than fivefold increase in risk. The study highlights the need for greater awareness, preventive strategies and policy changes within the bodybuilding community.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateMay 20, 2025

Two out of five patients with heart failure do not see a cardiologist even once a year and these patients are more likely to die

Two out of five heart failure patients do not see a cardiologist annually, significantly increasing mortality risk. Patients who receive regular cardiology care are 24% less likely to die in the following year, with optimal visits ranging from once to four times per year depending on recent hospitalization and diuretic use.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateMay 18, 2025

EuroPCR 2025 – The place to share solutions

The EuroPCR 2025 conference will cover interventions for coronary and peripheral vessels, valvular disease, heart failure, hypertension, and stroke. Sessions on complex topics will be held throughout the four-day programme, with a focus on sharing solutions.

SourcePCR·DateMay 5, 2025

Ready to Launch Program to spotlight careers in interventional cardiology at SCAI Scientific Sessions 2025

The Society for Cardiovascular Angiography and Interventions (SCAI) has launched a program called Ready to Launch, which connects medical students and early-career residents with leaders in interventional cardiology. The program aims to provide exposure to real-world clinical scenarios and lasting professional relationships.

Novel, balloon-assisted anterior mitral leaflet modification shown to be safe and effective for patients undergoing transcatheter mitral valve replacement

A novel technique, BATMAN, prevents LVOT obstruction during TMVR with a success rate of 92.7% and shorter procedure times. The study's findings suggest BATMAN may be an alternative to traditional LAMPOON techniques, offering improved efficacy and safety for certain patients.

With CCTA poised to transform PCI planning, SCAI/SCCT publish expert opinion document

The SCAI/SCCT expert opinion document presents a comprehensive framework for using CCTA to guide PCI. It outlines current evidence and future opportunities, providing practical guidance on image acquisition, interpretation, and procedural strategy. The document aims to bridge the gap between imaging and intervention, emphasizing educat...

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·TypeCommentary/editorial·DateMay 1, 2025

Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half

A large registry study found that single antiplatelet therapy is associated with lower six-month mortality and major bleeding risk compared to dual antiplatelet therapy after transcatheter aortic valve replacement. This new standard of care may provide better outcomes for high-risk patients with coronary artery disease.